Hidenobu Ishii

Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study

Fabrice Barlési, Johan Vansteenkiste, David R. Spigel et al. · The Lancet Oncology · 2018 · 394 citations

Medicine, Metronomic Therapy, Clinical Trials +9

Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy

Takaaki Tokito, Koichi Azuma, Akihiko Kawahara et al. · European Journal of Cancer · 2016 · 185 citations

Concurrent Chemoradiotherapy, Cancer Immunosurveillance, Pd-l1 Expression +10

Significance of Programmed Cell Death-Ligand 1 Expression and its Association with Survival in Patients with Small Cell Lung Cancer

Hidenobu Ishii, Koichi Azuma, Akihiko Kawahara et al. · Journal of Thoracic Oncology · 2014 · 175 citations

Medicine, Immunology, Cell Death +7

Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients

Norikazu Matsuo, Koichi Azuma, Kazuko Sakai et al. · Scientific Reports · 2016 · 93 citations · Full text

Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples

Hidenobu Ishii, Koichi Azuma, Kazuko Sakai et al. · Oncotarget · 2015 · 76 citations · Full text

Engineering, Immunology, Dna Analysis +20